Related Funds
Fund Name | Location |
4finance | Latvia, Riga, Vidzeme |
Bondshine Capital | China, Jiangsu, Nanjing |
CalCEF Clean Energy Angel Fund | California, San Francisco, United States |
Chugoku Bank | Japan, Okayama, Okayama Prefecture |
Chunghwa Telecom | New Taipei, Taiwan |
Cressey & Company | Chicago, Illinois, United States |
Halo | Belfast, Northern Ireland, United Kingdom |
JDS Capital Management | New York, New York, United States |
Koch Ventures | Dallas, Texas, United States |
Liil Ventures | Ciudad De León, Guanajuato, Mexico |
Mix Labs | - |
Numbrs | Switzerland, Zürich, Zurich |
Obunsha Ventures | Chiyoda, Japan |
Park West Asset Management | California, Larkspur, United States |
Schurz Communications | Indiana, Mishawaka, United States |
Twenty3 Capital | - |
United Parcel Service (UPS) | Atlanta, Georgia, United States |
Whittier Ventures | Boston, Massachusetts, United States |
Zhongjing Ruiyi | Beijing, China, Pinggu |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Virogin Biotech | $62M | 28 Sep 2020 | Vancouver, British Columbia, Canada | ||
Virogin Biotech | $62M | 22 Sep 2020 | Vancouver, British Columbia, Canada | ||
ORCA-TECH | 05 Aug 2020 | Xi'an, Shaanxi, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Virogin Biotech | $62M | 28 Sep 2020 | Vancouver, British Columbia, Canada | ||
Virogin Biotech | $62M | 22 Sep 2020 | Vancouver, British Columbia, Canada | ||
ORCA-TECH | 05 Aug 2020 | Xi'an, Shaanxi, China |